ClinicalTrials.gg
CompletedNCT07704086PRECICAUpdated Jul 15, 2026

Prehabilitation for Patients Undergoing Elective Cardiac Surgery

An interventional study of Physical exercise and Educational program and respiration physiotherapy in Coronary Artery Disease, Valvular Heart Disease and Chronic Thromboembolic Pulmonary Hypertension, sponsored by Hospital Universitario 12 de Octubre. Completed at 2 sites in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-15.

Sponsored by Hospital Universitario 12 de Octubre · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The objective of this clinical trial is to develop a novel rehabilitation model that, through the PRECICA program, will help to reduce perioperative and postoperative complications in the care process prior to planned cardiac surgery. This will be achieved by reducing the total postoperative hospital stay and the physical and psychological complications resulting from surgery. The target population for this trial is patients undergoing planned cardiac surgery due to chronic coronary artery disease, valvular pathology, chronic thromboembolic pulmonary hypertension and/or aortic injury. Consequently, the quality of life of these patients could be enhanced.

02

Conditions studied

  • Coronary Artery Disease
  • Valvular Heart Disease
  • Chronic Thromboembolic Pulmonary Hypertension
  • Aortic Diseases
03

In context

Coronary Artery Disease

4,857 studies on the registry are indexed under Coronary Artery Disease; 890 are open to participants now.

This study's enrollment of 86 is below the median of 124 across 3,006 interventional studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

Hospital Universitario 12 de Octubre is the lead sponsor of 33 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older.
  • Scheduled for elective cardiac surgery for one or more of the following indications:
  • Coronary artery disease.
  • Valvular heart disease.
  • Chronic thromboembolic pulmonary hypertension.
  • Aortic disease.

Exclusion criteria

Exclusion Criteria:

- Cognitive impairment that prevents understanding the study procedures or completing the intervention.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
86 participants (actual)

Study arms

  • Experimental
    Prehabilitation

    Other: Physical exercise · Other: Educational program and respiration physiotherapy

  • Other
    Standard care

    The standard of care is defined as a health education program and education in respiratory physiotherapy techniques.

    Other: Educational program and respiration physiotherapy

Interventions

  • OtherPhysical exercise

    A program designed to enhance muscular strength through a structured exercise program.

  • OtherEducational program and respiration physiotherapy

    The program will include a health education component and respiratory physiotherapy techniques.

06

What researchers measure

Primary outcomes

  1. Six minute walk test

    A functional capacity test (six-minute walk test) will be conducted to assess the subject's cardiovascular capacity.

    Time frame: This variable will be measured at four different time points; in the inclusion of the patient in the study, on the day of admission prior to surgery, one week after hospital discharge, and 2 months after surgery.

  2. Quality of life (EQ-5D-5L)

    The standard of health experienced

    Time frame: This variable will be measured at four different time points; in the inclusion of the patient in the study, on the day of admission prior to surgery, one week after hospital discharge, and 2 months after surgery.

Secondary outcomes

  1. Period of hospitalization

    The number of days spent in the hospital under surgical observation.

    Time frame: Through study completion, an average of 1 year

07

Study locations

2 sites
  • Hospital Universitario 12 de Octubre
    Madrid, Madrid 28041, Spain
  • Universidad Complutense de Madrid
    Madrid, Madrid, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2024 to primary completion in Jun 2026, 24 months.

Of 753 non-industry interventional studies with no phase under Coronary Artery Disease, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 53. This study's 24 months is below that.

Counting every sponsor, half of 930 studies reached it within 30 months; a quarter within 15 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
May 8, 2024
First posted
Jul 15, 2026
StartActual
Jun 1, 2024
Primary completionActual
Jun 1, 2026
CompletionActual
Jul 10, 2026
Last update
Jul 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07704086
Lead sponsor
Hospital Universitario 12 de Octubre
Responsible party
Juan Izquierdo García (Therapist, Hospital Universitario 12 de Octubre) — Principal investigator
First posted
Jul 15, 2026
Start date
Jun 1, 2024
Primary completion
Jun 1, 2026
Completion
Jul 10, 2026
Last update
Jul 15, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion